These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23347045)

  • 21. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
    Youssef MA; van Wely M; Al-Inany H; Madani T; Jahangiri N; Khodabakhshi S; Alhalabi M; Akhondi M; Ansaripour S; Tokhmechy R; Zarandi L; Rizk A; El-Mohamedy M; Shaeer E; Khattab M; Mochtar MH; van der Veen F
    Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of neither recombinant nor urinary luteinizing hormone was associated with an improvement in the outcome of autologous in vitro fertilization/intracytoplasmatic sperm injection cycles under regular clinical settings: a multicenter observational analysis.
    Schwarze JE; Crosby JA; Zegers-Hochschild F
    Fertil Steril; 2016 Dec; 106(7):1714-1717.e1. PubMed ID: 27678033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of recombinant LH in a group of unselected IVF patients.
    Lisi F; Rinaldi L; Fishel S; Lisi R; Pepe GP; Picconeri MG; Campbell A
    Reprod Biomed Online; 2002; 5(2):104-8. PubMed ID: 12419032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.
    König TE; van der Houwen LE; Overbeek A; Hendriks ML; Beutler-Beemsterboer SN; Kuchenbecker WK; Renckens CN; Bernardus RE; Schats R; Homburg R; Hompes PG; Lambalk CB
    Hum Reprod; 2013 Oct; 28(10):2804-12. PubMed ID: 23838159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
    Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
    Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis.
    Kolibianakis EM; Venetis CA; Diedrich K; Tarlatzis BC; Griesinger G
    Hum Reprod Update; 2009; 15(6):613-22. PubMed ID: 19561136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant LH administration in subsequent cycle after "unexpected" poor response to recombinant FSH monotherapy.
    Papaleo E; Vanni VS; Viganò P; La Marca A; Pagliardini L; Vitrano R; Zanirato M; Marsiglio E; Privitera L; Candiani M
    Gynecol Endocrinol; 2014 Nov; 30(11):813-6. PubMed ID: 24968088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
    Dahan MH; Agdi M; Shehata F; Son W; Tan SL
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved pregnancy rates with luteinizing hormone supplementation in patients undergoing ovarian stimulation for IVF.
    Paterson ND; Foong SC; Greene CA
    J Assist Reprod Genet; 2012 Jul; 29(7):579-83. PubMed ID: 22466744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of the antagonist/letrozole protocol for treating poor responders undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis.
    Song Y; Li Z; Wu X; Wang X; Xiao J; Wang B
    Gynecol Endocrinol; 2014 May; 30(5):330-4. PubMed ID: 24456013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mild versus conventional ovarian stimulation for IVF in poor responders: a systematic review and meta-analysis.
    Datta AK; Maheshwari A; Felix N; Campbell S; Nargund G
    Reprod Biomed Online; 2020 Aug; 41(2):225-238. PubMed ID: 32546333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S; Gunby J
    Cochrane Database Syst Rev; 2000; (4):CD002810. PubMed ID: 11034767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant luteinizing hormone priming in multiple follicular stimulation for in-vitro fertilization in downregulated patients.
    Lisi F; Caserta D; Montanino M; Berlinghieri V; Bielli W; Carfagna P; Carra MC; Costantino A; Lisi R; Poverini R; Ciardo F; Rago R; Marci R; Moscarini M
    Gynecol Endocrinol; 2012 Sep; 28(9):674-7. PubMed ID: 22313135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis.
    Kolibianakis EM; Kalogeropoulou L; Griesinger G; Papanikolaou EG; Papadimas J; Bontis J; Tarlatzis BC
    Hum Reprod Update; 2007; 13(5):445-52. PubMed ID: 17586849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WITHDRAWN: Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S; Gunby J
    Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD002810. PubMed ID: 17636708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of LH supplementation to the GnRH antagonist protocol in advanced reproductive ageing women: a prospective randomized controlled study.
    Younis JS; Izhaki I; Ben-Ami M
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):99-106. PubMed ID: 26304041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis.
    González-Comadran M; Durán M; Solà I; Fábregues F; Carreras R; Checa MA
    Reprod Biomed Online; 2012 Nov; 25(5):450-9. PubMed ID: 22999555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.